Massachusetts Financial Services’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
Other funds holding CAPR
JHC
Massachusetts Financial Services's CAPR Position: Q3 2026 in Review
Massachusetts Financial Services sold out of Capricor Therapeutics (CAPR) in Q3 2026, closing a stake of 10,095 shares — an estimated $243K sold.
Massachusetts Financial Services first reported a position in CAPR in Q1 2026 and held it in 2 quarters. The position peaked at $319K in Q1 2026. 101 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.
- Massachusetts Financial Services reported no remaining Capricor Therapeutics position as of Q3 2026 after selling out during the quarter.
- Massachusetts Financial Services sold 10,095 Capricor Therapeutics shares in Q3 2026, an estimated $243K.
- Massachusetts Financial Services first reported a position in Capricor Therapeutics in Q1 2026 and held it in 2 quarters.
- Massachusetts Financial Services's Capricor Therapeutics position peaked at $319K in Q1 2026.
- 101 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.
Based on Massachusetts Financial Services's 13F filing for Q3 2026, filed 12 Nov 2026.